Calimmune is a biotechnology company developing gene and stem cell therapies for treating rare and serious diseases.
Calimmune was founded in 2006 based on gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los AngelesLos Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies).